Stephen and Drew Sinatra present another installment of their timely Pulse Check series, where they discuss trending health topics and what you need to know right now
In recent press releases WW have acknowledged that GLP-1 medications are useful
People with severe gastrointestinal disease, including gastroparesis, may not tolerate semaglutide well since it slows gastric emptying
Each patient in the GLP-1RA group was matched to 1 or more (at most 4) counterparts in the DPP-4i group
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
Most GLP-1 agonists do not require dose adjustment for mild to moderate renal impairment, though specific agents have varying recommendations for severe impairment